Patient | Age (years) | Sex | Imaging modality | Imaging findings | Negative infectious findings | Positive infectious findings | WBC count | CRP | ESR | Procalcitonin | Lactate | Blood culture | Sputum culture | Other findings | Other results | AST | ALT | Albumin |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A | 15 | F | abd CT, CXR, chest CT | bibasilar infiltrates | RPP, urine Legionella, Mycoplasma pneumonia IgM (IFA) | Legionella antibody, Mycoplasma pneumonia IgM, IgG | 14.7 | 219 | 113 | n/a | no growth | n/a | RF neg | 55 | 76 | 2.4 | ||
B | 16 | M | CXR, chest CT | bilateral pulmonary infiltrates | urine Legionella, mycoplasma IgM, HIV, RPP, Lyme, West Nile | Legionella antibody, Mycoplasma pneumonia IgG | 20.6 | 334 | 106 | n/a | no growth | n/a | IgE 1935 | RF neg | 80 | NE | 2.1 | |
C | 17 | M | CXR, chest CT | bibasilar infiltrates | RPP, strep | 10.9 | 272 | n/a | n/a | n/a | n/a | 133 | 123 | 2.4 | ||||
E | 17 | F | CXR, abd u/s | bilateral interstitial infiltrates R > L | RPP, urine legionella, Mycoplasma pneumonia IgM (IFA), monospot, ANA, RF | Mycoplasma pneumonia IgM and IgG | 11.4 | 263 | 136 | n/a | no growth | n/a | 40 | NE | 2.1 | |||
F | 17 | M | CXR, chest CT | diffuse bilateral groundglass opacities with peripheral sparing | RPP | 12.3 | 183 | 77 | n/a | n/a | n/a | NE | NE | 3.1 | ||||
G | 18 | M | abd CT, CXR, chest CT, abd u/s | groundglass opacities with centrilobular nodules | RPP, urine Legionella, hepatitis panel | 17.2 | 252 | 98 | n/a | no growth | n/a | 166 | 129 | 2.1 | ||||
H | 20 | M | CXR, abd CT, chest CT | bilateral basilar groundglass opacities | RPP, urine Legionella, Lyme, Ehrlichia, Mycoplasma pneumonia IFA, HIV | Mycoplasma pneumonia IgM and IgG | 24 | 290 | 81 | 513 | coag neg staph; repeat no growth | NG | 39 | NE | 2.3 | |||
O | 20 | F | CXR | patchy infiltrate R lung base | RPP, strep, monospot, EBV IgM | EBV IgG | 10.1 | 105 | no growth | n/a | 10 | 17 | 3.7 | |||||
I | 20 | F | CXR, chest CT | bilateral reticular infiltrates | RPP, urine Legionella | 20.7 | 165 | 80 | n/a | no growth | NE | NE | 2.6 | |||||
J | 21 | M | CXR, chest CT | bilateral lower lobe consolidations | RPP, HIV | 8.6 | 338 | 67 | 0.16 | 1.3 | no growth | n/a | NE | 62 | 3.1 | |||
K | 24 | M | CXR, chest CT, abd u/s | extensive bilateral ground glass infiltrates, mediastinal lymphadenopathy | RPP | 17 | 261 | 66 | 0.72 | 2 | no growth | n/a | 214 | 333 | 2.8 | |||
L | 25 | M | CXR, chest CT | extensive bilateral consolidation with lower lobe predilection | RPP, urine Legionella, hepatitis panel | 14.9 | 229 | 90 | 0.07 | 1.3 | no growth | n/a | NE | 66 | 3.3 | |||
M | 32 | F | CXR, chest CT | extensive bilateral airspace consolidation | RPP, urine Legionella | 27 | 292 | 103 | 0.16 | 0.9 | no growth | BAL neg CX, AFB, fungal | ANA, RF neg | 45 | NE | 2.2 | ||
N | 33 | M | CXR, chest CT | bilateral groundglass opacities most pronounced lung bases | RPP | 14.9 | 181 | 54 | 0.65 | 1.9 | no growth | n/a | 38 | NE | 3 |